ReproNovo appoints Mark Altmeyer as Chairman of the Board
Altmeyer previously held senior roles at Arvelle Therapeutics, Axovant, Bristol Myers Squibb and Otsuka
Read MoreAppointments and people articles
Apr 2, 2026 | Appointments
Altmeyer previously held senior roles at Arvelle Therapeutics, Axovant, Bristol Myers Squibb and Otsuka
Read MoreApr 1, 2026 | Appointments
Kilcoyne previously held senior roles at AstraZeneca, Celgene, Sanofi, Roche and Eli Lilly
Read MoreMar 30, 2026 | Appointments
Werner previously held senior roles at Bristol Myers Squibb, AstraZeneca and Novartis
Read MoreMar 26, 2026 | Appointments
Jones currently serves on multiple boards, including NextCure
Read MoreMar 24, 2026 | Appointments
Neely previously worked at Medvantx, Roche and Eli Lilly
Read MoreMar 23, 2026 | Appointments
Hogben has previously worked across the US and global markets
Read MoreMar 20, 2026 | Appointments
The appointment coincides with Biologos’ 50th anniversary
Read MoreMar 18, 2026 | Appointments
Metzger was most recently Executive VP, Chief Technical Operations Officer at Ferring Pharmaceuticals
Read MoreMar 17, 2026 | Appointments
Thomas and Djuric formerly held senior roles at Roche and AbbVie, respectively
Read MoreMar 16, 2026 | Appointments
Seidel was previously Head of the Genomics Institute of the Novartis Research Foundation
Read MoreMar 12, 2026 | Appointments
The appointments have been announced amid team mergers
Read MoreMar 11, 2026 | Appointments
Andresen was CEO of T-Cypher Bio, an Oxford, UK-based immunotherapy company
Read More
